No Picture
Business

United States CFTC S&P 500 NC Net Positions up to $-238.7K from previous $-239.6K

Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet… […]

Next China: Et Tu, Tedros?
Business

Next China: Et Tu, Tedros?

We’ve detected unusual activity from your computer network To continue, please click the box below to let us know you’re not a robot. […]

Quest Diagnostics launches Alzheimer’s blood test for consumers
Business

Quest Diagnostics launches Alzheimer’s blood test for consumers

CHICAGO, July 31 (Reuters) – Quest Diagnostics (DGX.N) on Monday launched the first direct-to-consumer blood test to detect abnormal levels of beta amyloid, a key Alzheimer’s disease protein that can appear years before dementia symptoms arise.The $399 test, called AD-Detect, uses the same technology as a blood test the company began selling for use by… […]

Pearson reiterates outlook after strong demand boosts profit
Business

Pearson reiterates outlook after strong demand boosts profit

LONDON, July 31 (Reuters) – Global education group Pearson said it was on course to hit annual and mid-term targets after demand for English language learning, exams and qualifications helped it to beat market expectations with 44% growth in profit in its first half.The British group on Monday posted adjusted operating profit of 250 million… […]

Lamborghini could hit 10,000 sales this year, CEO says
Business

Lamborghini could hit 10,000 sales this year, CEO says

Revenues up 6.7% in H1 to 1.42 bln eurosOperating income up 7.2% in H1 to 456 mln eurosShipped 5,341 cars globally in H1, 1,625 in the U.S.EMEA largest region with 2,285 cars shipped in H1MILAN, July 31 (Reuters) – Lamborghini could sell 10,000 cars this year for the first time, its CEO said, as the… […]

Insight: Promising new Alzheimer’s drugs may benefit whites more than Blacks
Business

Insight: Promising new Alzheimer’s drugs may benefit whites more than Blacks

NEW YORK, July 31 (Reuters) – Groundbreaking treatments for Alzheimer’s disease that work by removing a toxic protein called beta amyloid from the brain may benefit whites more than Black Americans, whose disease may be driven by other factors, leading Alzheimer’s experts told Reuters.The two drugs – Leqembi, from partner biotech firms Eisai (4523.T) and… […]